
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 180 | $0.35 | $62.21 (0%) | 🛒 Add to cart |
| 360 | $0.31
Best per cap | $124.42 $111.38 (10%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.67 | $40.14 (0%) | 🛒 Add to cart |
| 90 | $0.60 | $60.20 $54.18 (10%) | 🛒 Add to cart |
| 120 | $0.56 | $80.27 $67.23 (16%) | 🛒 Add to cart |
| 180 | $0.53 | $120.41 $95.32 (21%) | 🛒 Add to cart |
| 270 | $0.51 | $180.61 $137.47 (24%) | 🛒 Add to cart |
| 360 | $0.50
Best per cap | $240.82 $179.61 (25%) | 🛒 Add to cart |
Synonyms
| |||
Similar products

More info:
fluoxetine
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that has fundamentally changed how we approach mood and anxiety disorders. When I first started in psychiatry back in the late 90s, the tricyclics were still dominant, but the side effect profiles were brutal. Then fluoxetine came along—Prozac was the brand name everyone knew—and it felt like we finally had something that patients could actually tolerate long-term. It wasn’t a miracle cure, nothing is, but it gave us a real fighting chance against major depressive disorder.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily function as dopamine D2 receptor antagonists, aripiprazole exhibits a unique mechanism as a partial dopamine agonist. This pharmacological profile allows it to stabilize dopamine activity rather than simply blocking it, creating what many clinicians describe as a “dopamine stabilizer” effect. The medication has received FDA approval for multiple psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder (as adjunct treatment), Tourette’s disorder, and irritability associated with autistic disorder.
Anafranil: Effective OCD and Depression Relief - Evidence-Based Review
Anafranil, known generically as clomipramine hydrochloride, is a tricyclic antidepressant (TCA) belonging to the dibenzazepine class. It’s primarily indicated for the treatment of obsessive-compulsive disorder (OCD), but its utility spans several psychiatric and even some neurological conditions due to its potent serotonergic effects. Unlike many newer agents, Anafranil has a robust, decades-long evidence base supporting its efficacy, particularly in treatment-resistant cases. It functions mainly as a serotonin reuptake inhibitor, though it also affects norepinephrine, which contributes to both its therapeutic benefits and side effect profile.
Asendin: A Potent Antidepressant for Treatment-Resistant Depression - Evidence-Based Review
Before we get to the formal headings, let me give you the real picture of Asendin. It’s not just another entry in the crowded antidepressant market; it’s a tricyclic antidepressant (TCA), specifically amoxapine, that occupies this fascinating, somewhat contentious niche. We initially viewed it as a fallback option when SSRIs failed, but over the years, I’ve seen its unique profile—part TCA, part subtle dopamine modulator—make a tangible difference for a specific subset of patients who feel nothing from the first-line drugs.
Bystolic: Advanced Blood Pressure Control with Vasodilatory Benefits - Evidence-Based Review
Bystolic represents one of those interesting beta-blockers that never quite got the mainstream attention it deserved, which is a shame because in my cardiology practice, I’ve found it to be remarkably versatile. The drug—nebivolol hydrochloride—is a third-generation beta-adrenergic receptor blocker with some unique properties that set it apart from the atenolols and metoprolols we all cut our teeth on. What makes Bystolic particularly compelling isn’t just its beta-1 selectivity, but its additional vasodilatory effects through nitric oxide modulation, something I first noticed when treating hypertensive patients who’d failed on other agents.
celexa
Celexa, known generically as citalopram hydrobromide, is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication, not a dietary supplement or medical device. It’s prescribed primarily for major depressive disorder (MDD) and off-label for anxiety disorders. This monograph will detail its formulation, mechanism, clinical use, and evidence base from both trial data and real-world application. 1. Introduction: What is Celexa? Its Role in Modern Medicine Celexa, or citalopram, belongs to the SSRI class, first approved by the FDA in 1998.
Clomid: Evidence-Based Ovulation Induction for Infertility - Comprehensive Review
Clomiphene citrate, commonly known by its brand name Clomid, represents one of the foundational oral medications in reproductive endocrinology. As a selective estrogen receptor modulator (SERM), it occupies this unique space where it paradoxically induces ovulation by temporarily blocking estrogen receptors in the hypothalamus. This creates a perceived estrogen deficiency that prompts the pituitary gland to increase secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The resulting hormonal cascade stimulates ovarian follicular development and maturation.
coreg
Carvedilol, marketed under the brand name Coreg, represents a significant advancement in cardiovascular pharmacotherapy. This non-selective beta-blocker with additional alpha-1 blocking activity has transformed how we manage several cardiac conditions that were previously difficult to treat effectively. Unlike traditional beta-blockers, carvedilol’s unique dual mechanism provides more comprehensive cardiovascular protection, particularly in patients with compromised cardiac function. The development journey wasn’t straightforward - our team initially debated whether combining beta and alpha blockade would create too much hemodynamic instability, but the clinical results have proven these concerns largely unfounded in properly managed patients.
Cymbalta: Effective Management of Depression and Chronic Pain - Evidence-Based Review
Duloxetine hydrochloride, marketed under the brand name Cymbalta, represents a significant class of medication known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It’s not a dietary supplement or medical device but a prescription pharmaceutical primarily used for managing major depressive disorder (MDD), generalized anxiety disorder (GAD), and certain chronic pain conditions like diabetic peripheral neuropathic pain and fibromyalgia. The development of Cymbalta was a massive undertaking at Lilly—I remember the early team meetings where we debated fiercely about the dual reuptake inhibition profile.
